Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Clin Cancer Res September 15 2015 21 (18) 4025-4025;

CCR 20th Anniversary Commentary

  • CCR 20th Anniversary Commentary | Free Article
    CCR 20th Anniversary Commentary: Simpson's Paradox and Neoadjuvant Trials
    Lisa A. Carey
    Clin Cancer Res September 15 2015 21 (18) 4027-4029; DOI:10.1158/1078-0432.CCR-14-3124

CCR Translations

  • CCR Translations
    Cancer Immunotherapy: More Is (Much) Better
    Yosef Yarden and Michael Sela
    Clin Cancer Res September 15 2015 21 (18) 4030-4032; DOI:10.1158/1078-0432.CCR-15-0996

  • CCR Translations
    SLFN11: Achilles' Heel or Troublemaker
    Heinrich Kovar
    Clin Cancer Res September 15 2015 21 (18) 4033-4034; DOI:10.1158/1078-0432.CCR-15-0883

CCR Perspectives in Drug Approval

  • CCR Perspectives in Drug Approval
    FDA Approval: Blinatumomab
    Donna Przepiorka, Chia-Wen Ko, Albert Deisseroth, Carolyn L. Yancey, Reyes Candau-Chacon, Haw-Jyh Chiu, Brenda J. Gehrke, Candace Gomez-Broughton, Robert C. Kane, Susan Kirshner, Nitin Mehrotra, Tiffany K. Ricks, Deborah Schmiel, Pengfei Song, Ping Zhao, Qing Zhou, Ann T. Farrell and Richard Pazdur
    Clin Cancer Res September 15 2015 21 (18) 4035-4039; DOI:10.1158/1078-0432.CCR-15-0612

Molecular Pathways

  • Molecular Pathways
    Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy
    Michele Maio, Alessia Covre, Elisabetta Fratta, Anna Maria Di Giacomo, Pietro Taverna, Pier Giorgio Natali, Sandra Coral and Luca Sigalotti
    Clin Cancer Res September 15 2015 21 (18) 4040-4047; DOI:10.1158/1078-0432.CCR-14-2914

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805
    Naomi B. Haas, Judith Manola, Bonnie Ky, Keith T. Flaherty, Robert G. Uzzo, Christopher J. Kane, Michael Jewett, Lori Wood, Christopher G. Wood, Michael B. Atkins, Janice J. Dutcher, George Wilding and Robert S. DiPaola
    Clin Cancer Res September 15 2015 21 (18) 4048-4054; DOI:10.1158/1078-0432.CCR-15-0215

  • Cancer Therapy: Clinical
    A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
    Don M. Benson Jr, Adam D. Cohen, Sundar Jagannath, Nikhil C. Munshi, Gary Spitzer, Craig C. Hofmeister, Yvonne A. Efebera, Pascale Andre, Robert Zerbib and Michael A. Caligiuri
    Clin Cancer Res September 15 2015 21 (18) 4055-4061; DOI:10.1158/1078-0432.CCR-15-0304

  • Cancer Therapy: Clinical
    Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
    Christine E. Brown, Behnam Badie, Michael E. Barish, Lihong Weng, Julie R. Ostberg, Wen-Chung Chang, Araceli Naranjo, Renate Starr, Jamie Wagner, Christine Wright, Yubo Zhai, James R. Bading, Julie A. Ressler, Jana Portnow, Massimo D'Apuzzo, Stephen J. Forman and Michael C. Jensen
    Clin Cancer Res September 15 2015 21 (18) 4062-4072; DOI:10.1158/1078-0432.CCR-15-0428

Personalized Medicine and Imaging

  • Personalized Medicine and Imaging
    Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
    Hui-Ming Chen, Ge Ma, Neil Gildener-Leapman, Samuel Eisenstein, Brian A. Coakley, Junko Ozao, John Mandeli, Celia Divino, Myron Schwartz, Max Sung, Robert Ferris, Johnny Kao, Lu-Hai Wang, Ping-Ying Pan, Eric C. Ko and Shu-Hsia Chen
    Clin Cancer Res September 15 2015 21 (18) 4073-4085; DOI:10.1158/1078-0432.CCR-14-2742

  • Personalized Medicine and Imaging
    Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy
    Sofia Khan, Rainer Fagerholm, Sajjad Rafiq, William Tapper, Kristiina Aittomäki, Jianjun Liu, Carl Blomqvist, Diana Eccles and Heli Nevanlinna
    Clin Cancer Res September 15 2015 21 (18) 4086-4096; DOI:10.1158/1078-0432.CCR-15-0296

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Aurora A Kinase Inhibition Selectively Synergizes with Histone Deacetylase Inhibitor through Cytokinesis Failure in T-cell Lymphoma
    Kelly M. Zullo, Yige Guo, Laurence Cooke, Xavier Jirau-Serrano, Michael Mangone, Luigi Scotto, Jennifer E. Amengual, Yinghui Mao, Renu Nandakumar, Serge Cremers, Jimmy Duong, Daruka Mahadevan and Owen A. O'Connor
    Clin Cancer Res September 15 2015 21 (18) 4097-4109; DOI:10.1158/1078-0432.CCR-15-0033

  • Cancer Therapy: Preclinical
    Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
    Helle J. Jacobsen, Thomas T. Poulsen, Anna Dahlman, Ida Kjær, Klaus Koefoed, Jette W. Sen, Dietmar Weilguny, Bolette Bjerregaard, Christina R. Andersen, Ivan D. Horak, Mikkel W. Pedersen, Michael Kragh and Johan Lantto
    Clin Cancer Res September 15 2015 21 (18) 4110-4122; DOI:10.1158/1078-0432.CCR-14-3312

  • Cancer Therapy: Preclinical
    Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer
    Amit Mehta, Lisa Zhang, Myriem Boufraqech, Yi Liu-Chittenden, Yaqin Zhang, Dhaval Patel, Sean Davis, Avi Rosenberg, Kris Ylaya, Rachel Aufforth, Zhuyin Li, Min Shen and Electron Kebebew
    Clin Cancer Res September 15 2015 21 (18) 4123-4132; DOI:10.1158/1078-0432.CCR-14-3251

  • Cancer Therapy: Preclinical
    Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate Cancer
    Yezi Zhu, Chengfei Liu, Cameron Armstrong, Wei Lou, Amandeep Sandher and Allen C. Gao
    Clin Cancer Res September 15 2015 21 (18) 4133-4142; DOI:10.1158/1078-0432.CCR-15-0269

  • Cancer Therapy: Preclinical
    Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents
    Irina A. Vasilevskaya, Muthu Selvakumaran, Lucia Cabal Hierro, Sara R. Goldstein, Jeffrey D. Winkler and Peter J. O'Dwyer
    Clin Cancer Res September 15 2015 21 (18) 4143-4152; DOI:10.1158/1078-0432.CCR-15-0352

  • Cancer Therapy: Preclinical
    Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models
    Teresa Troiani, Stefania Napolitano, Giulia Martini, Erika Martinelli, Claudia Cardone, Nicola Normanno, Donata Vitagliano, Floriana Morgillo, Francesca Fenizia, Matilde Lambiase, Luigi Formisano, Roberto Bianco, Davide Ciardiello and Fortunato Ciardiello
    Clin Cancer Res September 15 2015 21 (18) 4153-4164; DOI:10.1158/1078-0432.CCR-15-0211

  • Cancer Therapy: Preclinical | AuthorChoice
    Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions
    Marc Damelin, Alexander Bankovich, Albert Park, Jorge Aguilar, Wade Anderson, Marianne Santaguida, Monette Aujay, Sarah Fong, Kiran Khandke, Virginia Pulito, Elana Ernstoff, Paul Escarpe, Jeffrey Bernstein, Marybeth Pysz, Wenyan Zhong, Erik Upeslacis, Judy Lucas, Justin Lucas, Timothy Nichols, Kathryn Loving, Orit Foord, Johannes Hampl, Robert Stull, Frank Barletta, Hadi Falahatpisheh, Puja Sapra, Hans-Peter Gerber and Scott J. Dylla
    Clin Cancer Res September 15 2015 21 (18) 4165-4173; DOI:10.1158/1078-0432.CCR-15-0695

Biology of Human Tumors

  • Biology of Human Tumors
    Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing
    Marina Parry, Matthew J.J. Rose-Zerilli, Viktor Ljungström, Jane Gibson, Jun Wang, Renata Walewska, Helen Parker, Anton Parker, Zadie Davis, Anne Gardiner, Neil McIver-Brown, Christina Kalpadakis, Aliki Xochelli, Achilles Anagnostopoulos, Claudia Fazi, David Gonzalez de Castro, Claire Dearden, Guy Pratt, Richard Rosenquist, Margaret Ashton-Key, Francesco Forconi, Andrew Collins, Paolo Ghia, Estella Matutes, Gerassimos Pangalis, Kostas Stamatopoulos, David Oscier and Jonathan C. Strefford
    Clin Cancer Res September 15 2015 21 (18) 4174-4183; DOI:10.1158/1078-0432.CCR-14-2759

  • Biology of Human Tumors
    SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma
    Sai-Wen Tang, Sven Bilke, Liang Cao, Junko Murai, Fabricio G. Sousa, Mihoko Yamade, Vinodh Rajapakse, Sudhir Varma, Lee J. Helman, Javed Khan, Paul S. Meltzer and Yves Pommier
    Clin Cancer Res September 15 2015 21 (18) 4184-4193; DOI:10.1158/1078-0432.CCR-14-2112

  • Biology of Human Tumors | AuthorChoice
    Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival
    Sébastien Salas, Celine Brulard, Philippe Terrier, Dominique Ranchere-Vince, Agnes Neuville, Louis Guillou, Marick Lae, Agnes Leroux, Olivier Verola, Kurtz Jean-Emmanuel, Sylvie Bonvalot, Jean-Yves Blay, Axel Le Cesne, Alain Aurias, Jean-Michel Coindre and Frederic Chibon
    Clin Cancer Res September 15 2015 21 (18) 4194-4200; DOI:10.1158/1078-0432.CCR-14-2910

  • Biology of Human Tumors
    Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma
    Angela C. Hirbe, Sonika Dahiya, Christopher A. Miller, Tiandao Li, Robert S. Fulton, Xiaochun Zhang, Sandra McDonald, Katherine DeSchryver, Eric J. Duncavage, Jessica Walrath, Karlyne M. Reilly, Haley J. Abel, Melike Pekmezci, Arie Perry, Timothy J. Ley and David H. Gutmann
    Clin Cancer Res September 15 2015 21 (18) 4201-4211; DOI:10.1158/1078-0432.CCR-14-3049

  • Biology of Human Tumors
    Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer
    Grant D. Stewart, Fiach C. O'Mahony, Alexander Laird, Lel Eory, Alexander L.R. Lubbock, Alan Mackay, Jyoti Nanda, Marie O'Donnell, Peter Mullen, S. Alan McNeill, Antony C.P. Riddick, Daniel Berney, Axel Bex, Michael Aitchison, Ian M. Overton, David J. Harrison and Thomas Powles
    Clin Cancer Res September 15 2015 21 (18) 4212-4223; DOI:10.1158/1078-0432.CCR-15-0207

  • Biology of Human Tumors
    Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
    Michael P. Gustafson, Yi Lin, Jonathan S. Bleeker, Deepti Warad, Matthew K. Tollefson, Paul L. Crispen, Peggy A. Bulur, Susan M. Harrington, Rebecca R. Laborde, Dennis A. Gastineau, Bradley C. Leibovich, John C. Cheville, Eugene D. Kwon and Allan B. Dietz
    Clin Cancer Res September 15 2015 21 (18) 4224-4233; DOI:10.1158/1078-0432.CCR-15-0260

  • Biology of Human Tumors
    Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
    Atsushi Yamada, Takahiro Horimatsu, Yoshinaga Okugawa, Naoshi Nishida, Hajime Honjo, Hiroshi Ida, Tadayuki Kou, Toshihiro Kusaka, Yu Sasaki, Makato Yagi, Takuma Higurashi, Norio Yukawa, Yusuke Amanuma, Osamu Kikuchi, Manabu Muto, Yoshiyuki Ueno, Atsushi Nakajima, Tsutomu Chiba, C. Richard Boland and Ajay Goel
    Clin Cancer Res September 15 2015 21 (18) 4234-4242; DOI:10.1158/1078-0432.CCR-14-2793

Corrections

  • Corrections
    Correction: PID1 (NYGGF4), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas
    Clin Cancer Res September 15 2015 21 (18) 4243-4243; DOI:10.1158/1078-0432.CCR-15-1523

  • Corrections
    Correction: Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel—Letter
    Clin Cancer Res September 15 2015 21 (18) 4244-4244; DOI:10.1158/1078-0432.CCR-15-1693

Back to top
PreviousNext
Clinical Cancer Research: 21 (18)
September 2015
Volume 21, Issue 18
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma
  • A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
  • Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
  • Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal Cancer
  • Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma

Jump to

  • Highlights
  • CCR 20th Anniversary Commentary
  • CCR Translations
  • CCR Perspectives in Drug Approval
  • Molecular Pathways
  • Cancer Therapy: Clinical
  • Personalized Medicine and Imaging
  • Cancer Therapy: Preclinical
  • Biology of Human Tumors
  • Corrections
Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement